PALISADE CAPITAL MANAGEMENT, LP Q4 2019 Filing

Filed February 4, 2020

Portfolio Value

$3.5T

Holdings

410

Report Date

Q4 2019

Filing Type

13F-HR

All Holdings (410 positions)

#	Stock	Shares	Value	% Portfolio	Type
401	DEODIAGEO P L C	1,235	$208.0M	0.01%
402	FEYECHFFIREEYE INC	11,000	$182.0M	0.01%
403	—PARATEK PHARMACEUTICALS INC	40,800	$164.0M	0.00%
404	—RETROPHIN INC	11,502	$163.0M	0.00%
405	CLVSEURCLOVIS ONCOLOGY INC	14,000	$146.0M	0.00%
406	NYCBEURNEW YORK CMNTY BANCORP INC	11,000	$132.0M	0.00%
407	SENS1GBPSENSEONICS HLDGS INC	75,400	$69.0M	0.00%
408	—NANTHEALTH INC	41,000	$42.0M	0.00%
409	—PALATIN TECHNOLOGIES INC	19,010	$15.0M	0.00%
410	—ENCORE CAP GROUP INC	15,000	$15.0M	0.00%

PreviousPage 5 of 5